|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net (loss) income to cash provided by operations: | |||||
| (Reversal of) provision for credit losses | |||||
| Provision for asset impairment | |||||
| Depreciation and amortization expense | |||||
| Reduction in the carrying amount of the right-of-use asset | |||||
| Net realized loss (gain) on disposition of commercial loans | |||||
| Realized gain on sale of commercial loan | |||||
| Amortization of acquired above- and below-market leases, net | |||||
| Amortization of equity-based compensation | |||||
| Amortization of debt finance costs to operating expense | |||||
| Amortization of debt finance costs to interest expense | |||||
| Amortization of origination fees | |||||
| Amortization of deferred exit fees | |||||
| Amortization of loan extension fees | |||||
| Changes in assets and liabilities: | |||||
| Accrued interest receivable | |||||
| Accrued expenses | |||||
| Accrued expenses and other liabilities | |||||
| Accrued interest payable | |||||
| Due to related parties | |||||
| Prepaid expenses and other assets | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Origination/funding of commercial loans | |||||
| Loan extension fees received on commercial loans | |||||
| Principal repayments of commercial loans | |||||
| Proceeds from sale of commercial loan | |||||
| Real estate capital expenditures | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Redemptions of common stock | |||||
| Repurchase of preferred stock | |||||
| Payment of offering costs | |||||
| Reimbursement Of Offering Costs | |||||
| Proceeds from repurchase agreements | |||||
| Principal repayments of repurchase agreements | |||||
| Proceeds From Mortgage Loan Payable | |||||
| Proceeds from credit facility | |||||
| Principal repayments of credit facility | |||||
| Proceeds from sale of loan participations | |||||
| Principal repayments of loan participations | |||||
| Debt finance costs | |||||
| Distributions paid to common stockholders | |||||
| Distributions paid to preferred stockholders | |||||
| Net cash used in financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Amortization of deferred exit fees due to related party | |||||
| Interest paid | |||||
| Net assets acquired upon foreclosure of commercial loans | |||||
| Deferred interest capitalized on real estate loan | |||||
| Accrued stockholder servicing fee due to related party | |||||
| Accrued capital expenditures | |||||
| Distribution reinvestment | |||||
Loading...